Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04202588
Other study ID # NationCor-FGID
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2020
Est. completion date January 2022

Study information

Verified date January 2022
Source Hong Kong Baptist University
Contact Sonia Low, BNurse
Phone 852-34116523
Email soniagoh@hkbu.edu.hk
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The investigators will conduct a multicenter cross-sectional study to discover symptom characteristics, quality of life, severity of anxiety and depression, status of lactose intolerance and treatment satisfaction of current Chinese Medicine (CM) regimens of outpatients with FGIDs. In the meanwhile, the investigators will also analyze the characters of CM patterns and corresponding elements, then explore the potential relationship between CM patterns and FGIDs' subtypes.


Description:

This is a multicenter cross-sectional study to discover symptom characteristics, quality of life, severity of anxiety and depression, status of lactose intolerance and treatment satisfaction of current Chinese Medicine (CM) regimens of outpatients with FGIDs. Afterwards, the investigators will explore the potential relationship between CM patterns and FGIDs' subtypes based on collected information. It is estimated that 4,632 outpatients from 18 centers across China will be recruited. Various demographic and disease-related information will be documented, including name, gender, age, education level, marital status, job category, disease course, medical consultation experience, current CM regimens and rationale, and treatment satisfaction. Patients will also complete a series of scales, containing, Rome IV Diagnostic Questionnaire, Patient-Reported Outcome (PRO) scale, the 36-Item Short Form Survey (SF-36), Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), lactose food frequency questionnaire (Lactose FFQ) and CM pattern scale. The primary outcome will be the symptom characteristics of outpatients with FGIDs. Secondary outcomes include population characteristics of FGID patients (quality of life, emotional status, lactose intolerance status, and satisfaction level of CM interventions), and potential association between CM patterns and FGIDs' subtypes.


Recruitment information / eligibility

Status Recruiting
Enrollment 4632
Est. completion date January 2022
Est. primary completion date January 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Symptoms onset at least 3 months - Meet the diagnostic criteria of FGIDs - Informed consent and ability to read and understand questionnaires Exclusion Criteria: - Combined with organic gastrointestinal diseases - Appearance of gastrointestinal alarm symptoms - Combined with mental disorders

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Hong Kong Linda Zhong Kowloon Tong Kowloon

Sponsors (18)

Lead Sponsor Collaborator
Hong Kong Baptist University Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Beijing Hospital of Traditional Chinese Medicine Affiliated with Capital Medical University, First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Higher Education Mega Center Branch of Guangdong Provincial Hospital of Chinese Medicine, Hospital of Shanxi University of Traditional Chinese Medicine, Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Liuzhou Traditional Chinese Medical Hospital, Second Affiliated Hospital of Fujian Traditional Chinese Medical University, Shaanxi Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University, Wuhan Hospital of Traditional Chinese and Western Medicine, Xiyuan Hospital of China Academy of Chinese Medical Sciences

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Distribution of different subtypes with Functional gastrointestinal disorders (FGIDs) in China The percentage of the different subtypes with FGIDs by Rome IV Diagnostic Criteria 2 years
Primary The health-related quality of life (HRQOL) of outpatients with FGIDs in China The HRQOL scale contains 36 questions scoring from 0 to 4. Higher score means a worse outcome. The highest total score is 144. 2 years
Secondary Demographic characteristics of outpatients with FGIDs in China Including age, gender, education level, marital status and job categories 2 years
Secondary Quality of life of outpatients with FGIDs in China 36-Item Short Form Survey (SF-36) will be used. Thirty items are contained and each item is scored on a 0 to 100 range. A high score defines a more favorable health state. 2 years
Secondary HAMA scoring of outpatients with FGIDs in China Hamilton Anxiety Scale (HAMA) contained and 14 questions scoring form 0 to 4. A high score means a worse anxiety state. 2 years
Secondary HAMD scoring of outpatients with FGIDs in China Hamilton Depression Scale (HAMD) contained and 17 questions scoring form 0 to 4. A high score means a worse depression state. 2 years
Secondary Treatment satisfaction score of CM interventions in outpatients with FGIDs in China Treatment satisfaction will be evaluated using a single question scoring from 0 to 4. A higher score means worse satisfaction. 2 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05936112 - Quantification of Fecal Calprotectin Concentration Difference Between Infants Aged Under 4 Months Old Suffering From Functional Gastrointestinal Disorders (FGID) and Infants Aged Under 4 Months Old Free From Disorders : a Transversal Case-control Monocentric Study N/A
Completed NCT02565355 - Targeted Food Elimination for Treatment of Functional Gastrointestinal Diseases in Children N/A
Completed NCT02657668 - Emotion Focused Therapy in Irritable Bowel Syndrome Patients N/A
Completed NCT02731664 - GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans Phase 1
Recruiting NCT06205446 - Application of Diaphragmatic Breathing in Patients With Disorders of Gut-brain Interaction N/A
Recruiting NCT05718960 - Traditional Dietary Advice Versus Reassurance-alone in Postprandial Functional Dyspepsia N/A
Terminated NCT04247100 - A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders N/A
Recruiting NCT03625674 - Impact of Stigma on Compliance to Medication in Functional Dyspepsia N/A
Completed NCT03252743 - ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study. N/A
Recruiting NCT05832528 - Low FODMAP Diet in FD (PDS) N/A
Completed NCT02936713 - Effect of Controlled Diet Combined With a Fermented Milk Product on Gas-related Symptoms N/A
Terminated NCT01712412 - Phase 2a Study of IW-9179 to Treat Functional Dyspepsia Phase 2
Completed NCT00564525 - Study of Medication for Functional Abdominal Pain in Children Phase 4
Recruiting NCT05987813 - Transcutaneous Electric Nerve Stimulation (TENS) for Vagal Modulation N/A
Completed NCT04155801 - A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal Disturbances N/A
Recruiting NCT05880199 - BSGM to Evaluate Patients With GI Symptoms
Recruiting NCT04625881 - Effects of an Apple Derived Fibre Supplement on Constipation Phase 3
Completed NCT03608735 - Prevalence of Functional Gastrointestinal Disorders (FGIDs), Related Signs and Symptoms in Infants/Toddlers in Thailand
Recruiting NCT04773158 - Systematic Pediatric Assessment of Rome Criteria N/A
Completed NCT02306369 - Internet-delivered CBT for Irritable Bowel Syndrome in Adolescents N/A